A new paradigm for drug delivery

Bio-Path strives to treat and eventually cure life-threatening diseases through the delivery of non-toxic antisense therapeutics with our neutral liposome-based DNAbilizeā„¢ technology.

Learn More

Bio-Path is a biotechnology company focused on the clinical development of therapeutics by utilizing DNAbilizeā„¢, our novel and patented method for producing antisense DNA therapeutics for a broad spectrum of indications, including cancer.